AU2001249359A1 - Constitutive androstane receptor - Google Patents

Constitutive androstane receptor

Info

Publication number
AU2001249359A1
AU2001249359A1 AU2001249359A AU4935901A AU2001249359A1 AU 2001249359 A1 AU2001249359 A1 AU 2001249359A1 AU 2001249359 A AU2001249359 A AU 2001249359A AU 4935901 A AU4935901 A AU 4935901A AU 2001249359 A1 AU2001249359 A1 AU 2001249359A1
Authority
AU
Australia
Prior art keywords
androstane receptor
constitutive androstane
constitutive
receptor
androstane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001249359A
Inventor
Jon L. Collins
Derek J. Parks
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2001249359A1 publication Critical patent/AU2001249359A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/723—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AU2001249359A 2000-03-23 2001-03-22 Constitutive androstane receptor Abandoned AU2001249359A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19149300P 2000-03-23 2000-03-23
US60191493 2000-03-23
PCT/US2001/009233 WO2001071361A2 (en) 2000-03-23 2001-03-22 Constitutive androstane receptor

Publications (1)

Publication Number Publication Date
AU2001249359A1 true AU2001249359A1 (en) 2001-10-03

Family

ID=22705709

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001249359A Abandoned AU2001249359A1 (en) 2000-03-23 2001-03-22 Constitutive androstane receptor

Country Status (3)

Country Link
US (1) US6579686B2 (en)
AU (1) AU2001249359A1 (en)
WO (1) WO2001071361A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040115627A1 (en) * 2000-04-12 2004-06-17 Judy Raucy Compositions and methods for induction of proteins involved in xenobiotic metabolism
US20040077080A1 (en) * 2000-04-12 2004-04-22 Judy Raucy Compositions and methods for induction of proteins involved in xenobiotic metabolism
MXPA02009869A (en) * 2000-04-12 2005-02-17 Judy Raucy Compositions and methods for induction of proteins involved in xenobiotic metabolism.
JP4884640B2 (en) * 2000-09-21 2012-02-29 ベイラー カレッジ オブ メディスン Screening system and method for identifying modulators of xenobiotic metabolism
GB201015569D0 (en) * 2010-09-16 2010-10-27 Medical Res Council Blood assay for prions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003523498A (en) 1998-03-30 2003-08-05 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Methods and compounds for modulating the binding of nuclear receptor co-activator
US6410245B1 (en) * 1998-04-01 2002-06-25 Affymax, Inc. Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions
FR2780512B1 (en) 1998-06-25 2003-10-17 Lipha USE OF RECEIVERS OF THE REV-ERB FAMILY FOR SCREENING OF SUBSTANCES USEFUL IN THE TREATMENT OF LYSID METABOLISM DYSFUNCTIONS

Also Published As

Publication number Publication date
US20010055815A1 (en) 2001-12-27
WO2001071361A2 (en) 2001-09-27
US6579686B2 (en) 2003-06-17
WO2001071361A3 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
AU2001256733A1 (en) Melanin-concentrating hormone antagonist
AU2002323098A1 (en) Selective estrogen receptor modulators
AU2001228665A1 (en) Toll-like receptor
AU2001264256A1 (en) Plaster
AU2001284934A1 (en) Steroid derived antibiotics
AU2001210409A1 (en) Touchpad
AU2001252679A1 (en) Plaster
AU2001234766A1 (en) G-protein coupled receptors
AU2001234458A1 (en) Note feeder
AU2001240097A1 (en) G protein-coupled receptors
AU2001251175A1 (en) G-protein coupled receptors
AU2001249359A1 (en) Constitutive androstane receptor
AU2001258949A1 (en) Control cable
AU2001240019A1 (en) G-protein coupled receptors
AU2001223882A1 (en) Receptor
EP1205957A3 (en) Switch-disconnector control unit
AUPQ563400A0 (en) Novel receptor
AU2002212140A1 (en) Inflammation related g-protein coupled receptor
AU2001249922A1 (en) G protein-coupled receptors
AU2001259322A1 (en) G protein-coupled receptors
AU2001275362A1 (en) Nuclear hormone receptors
EP1213188A3 (en) Control device
AU2001258432A1 (en) Z-crank mechanism
AU5545400A (en) Estrogen receptor
AU2001294619A1 (en) Adp-glucose receptor